Profound Medical Corp
TSX:PRN
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CA |
Profound Medical Corp
TSX:PRN
|
278.2m CAD | 28.3 | ||
US |
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 4.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 18.6 | ||
US |
Stryker Corp
NYSE:SYK
|
123.5B USD | 5.9 | ||
IE |
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108B USD | 7.3 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 3.5 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 2.7 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
375.2B CNY | 10.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.5 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.7B USD | 13.1 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.